Together with 23 other partner laboratories, an in vitro method is to be validated in which neurite growth or branching as well as neuronal differentiation from the mouse precursor cell line C17.2 is to be assessed. The test subjects will be examined in the presence of the three receptor antagonists AGN193109 for RAR, HX531 for RXR and GSK3787 for PPARδ.
The application deadline has been extended to June 15, 2024.
To apply, please send your offer to Philippe.Hubert[at]ed-pepper.eu and Andrea.Rivero-Arze[at]ed-pepper.eu, following the instructions in the attached document below.
Draft validation and further information: